Mitochondrial impairment but not peripheral inflammation predicts greater Gulf War illness severity.

Beatrice A Golomb, Roel Sanchez Baez, Jan M Schilling, Mehul Dhanani, McKenzie J Fannon, Brinton K Berg, Bruce J Miller, Pam R Taub, Hemal H Patel
Author Information
  1. Beatrice A Golomb: Department of Medicine, University of California, San Diego, 9500 Gilman Drive #0995, La Jolla, CA, 92093-0995, USA. bgolomb@ucsd.edu.
  2. Roel Sanchez Baez: Department of Medicine, University of California, San Diego, 9500 Gilman Drive #0995, La Jolla, CA, 92093-0995, USA.
  3. Jan M Schilling: VA San Diego Healthcare System and Department of Anesthesiology, University of California, San Diego, San Diego, CA, 92161, USA.
  4. Mehul Dhanani: VA San Diego Healthcare System and Department of Anesthesiology, University of California, San Diego, San Diego, CA, 92161, USA.
  5. McKenzie J Fannon: VA San Diego Healthcare System and Department of Anesthesiology, University of California, San Diego, San Diego, CA, 92161, USA.
  6. Brinton K Berg: Department of Medicine, University of California, San Diego, 9500 Gilman Drive #0995, La Jolla, CA, 92093-0995, USA.
  7. Bruce J Miller: Department of Medicine, University of California, San Diego, 9500 Gilman Drive #0995, La Jolla, CA, 92093-0995, USA.
  8. Pam R Taub: Division of Cardiovascular Medicine, Department of Medicine, University of California, San Diego, La Jolla, CA, 92037, USA.
  9. Hemal H Patel: VA San Diego Healthcare System and Department of Anesthesiology, University of California, San Diego, San Diego, CA, 92161, USA.

Abstract

Gulf War illness (GWI) is an important exemplar of environmentally-triggered chronic multisymptom illness, and a potential model for accelerated aging. Inflammation is the main hypothesized mechanism for GWI, with mitochondrial impairment also proposed. No study has directly assessed mitochondrial respiratory chain function (MRCF) on muscle biopsy in veterans with GWI (VGWI). We recruited 42 participants, half VGWI, with biopsy material successfully secured in 36. Impaired MRCF indexed by complex I and II oxidative phosphorylation with glucose as a fuel source (CI&CIIOXPHOS) related significantly or borderline significantly in the predicted direction to 17 of 20 symptoms in the combined sample. Lower CI&CIIOXPHOS significantly predicted GWI severity in the combined sample and in VGWI separately, with or without adjustment for hsCRP. Higher-hsCRP (peripheral inflammation) related strongly to lower-MRCF (particularly fatty acid oxidation (FAO) indices) in VGWI, but not in controls. Despite this, whereas greater MRCF-impairment predicted greater GWI symptoms and severity, greater inflammation did not. Surprisingly, adjusted for MRCF, higher hsCRP significantly predicted lesser symptom severity in VGWI selectively. Findings comport with a hypothesis in which the increased inflammation observed in GWI is driven by FAO-defect-induced mitochondrial apoptosis. In conclusion, impaired mitochondrial function-but not peripheral inflammation-predicts greater GWI symptoms and severity.

References

  1. Ann Med. 2005;37(3):222-32 [PMID: 16019721]
  2. J Pers Med. 2021 Jun 04;11(6): [PMID: 34199819]
  3. Sci Am. 1997 Aug;277(2):40-7 [PMID: 9245840]
  4. Biol Neonate. 1990;58 Suppl 1:54-69 [PMID: 2265220]
  5. Mutat Res. 1996 Dec;366(3):197-238 [PMID: 9033668]
  6. Mol Carcinog. 2006 Sep;45(9):635-47 [PMID: 16491484]
  7. Cardiovasc Drugs Ther. 1998 Sep;12(4):347-53 [PMID: 9825179]
  8. JAMA. 1998 Sep 16;280(11):981-8 [PMID: 9749480]
  9. Biopsychosoc Med. 2008 Feb 22;2:7 [PMID: 18294386]
  10. Biofactors. 1998;7(3):187-90 [PMID: 9568243]
  11. Pediatrics. 2007 Dec;120(6):e1386-92 [PMID: 18055656]
  12. Environ Health. 2015 Jan 09;14:4 [PMID: 25575675]
  13. BMJ Case Rep. 2015 Oct 05;2015: [PMID: 26438672]
  14. J Occup Environ Med. 2017 Oct;59(10):1000-1006 [PMID: 28991135]
  15. Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):171-8 [PMID: 15982685]
  16. EBioMedicine. 2017 Dec;26:126-131 [PMID: 29137891]
  17. Nat Rev Genet. 2015 Sep;16(9):530-42 [PMID: 26281784]
  18. J Vis Exp. 2014 Sep 10;(91):51812 [PMID: 25285722]
  19. J Diet Suppl. 2023;20(4):563-581 [PMID: 35229700]
  20. Toxicol Appl Pharmacol. 2007 Apr 1;220(1):92-107 [PMID: 17275868]
  21. BMC Res Notes. 2019 Dec 18;12(1):816 [PMID: 31852524]
  22. Annu Rev Pharmacol Toxicol. 2000;40:353-88 [PMID: 10836141]
  23. Proteomics Clin Appl. 2017 Sep;11(9-10): [PMID: 28371386]
  24. Med Hypotheses. 2005;64(2):357-66 [PMID: 15607571]
  25. FEBS J. 2016 Jun;283(11):2181-96 [PMID: 27060259]
  26. R Soc Open Sci. 2021 Mar 17;8(3):200974 [PMID: 33959308]
  27. Int J Environ Res Public Health. 2021 Mar 03;18(5): [PMID: 33802381]
  28. Free Radic Biol Med. 2013 Oct;63:108-14 [PMID: 23619127]
  29. Psychol Med. 2008 Jul;38(7):953-61 [PMID: 17892626]
  30. Int J Environ Res Public Health. 2021 Mar 03;18(5): [PMID: 33802272]
  31. Int J Environ Res Public Health. 2021 Feb 09;18(4): [PMID: 33572101]
  32. Handb Clin Neurol. 2015;131:191-203 [PMID: 26563790]
  33. Cell Mol Life Sci. 1997 Jun;53(6):527-32 [PMID: 9230931]
  34. Aging Dis. 2022 Apr 1;13(2):583-613 [PMID: 35371600]
  35. Blood Coagul Fibrinolysis. 2013 Oct;24(7):736-41 [PMID: 23751609]
  36. Am J Cardiovasc Drugs. 2008;8(6):373-418 [PMID: 19159124]
  37. Am J Med Genet A. 2004 Nov 15;131(1):50-8 [PMID: 15368478]
  38. Environ Sci Pollut Res Int. 2020 Jul;27(20):24799-24814 [PMID: 32358751]
  39. Cephalalgia. 2009 Jul;29(7):719-28 [PMID: 19220304]
  40. Mol Nutr Food Res. 2018 May;62(9):e1700941 [PMID: 29578301]
  41. Cardiol J. 2019;26(2):147-156 [PMID: 30835327]
  42. Int J Clin Exp Med. 2009;2(1):1-16 [PMID: 19436827]
  43. Free Radic Biol Med. 2003 Jul 1;35(1):1-8 [PMID: 12826250]
  44. Biochim Biophys Acta. 2014 Aug;1842(8):1198-207 [PMID: 24252612]
  45. Nihon Rinsho. 2005 Oct;63(10):1720-6 [PMID: 16218381]
  46. Environ Int. 2022 Feb;160:107081 [PMID: 35021149]
  47. Mil Med. 2018 Mar 1;183(suppl_1):552-555 [PMID: 29635560]
  48. Chem Res Toxicol. 2021 May 17;34(5):1337-1347 [PMID: 33913694]
  49. PLoS One. 2017 Sep 14;12(9):e0184832 [PMID: 28910366]
  50. Drug Metab Rev. 2005;37(2):311-25 [PMID: 15931767]
  51. Reprod Toxicol. 2019 Oct;89:83-92 [PMID: 31315019]
  52. Am J Epidemiol. 2002 Jun 1;155(11):1033-44 [PMID: 12034582]
  53. Mil Med. 2001 Jun;166(6):510-9 [PMID: 11413729]
  54. Int J Cardiol. 2013 Sep 1;167(5):1860-6 [PMID: 22626835]
  55. Int J Environ Res Public Health. 2020 Sep 29;17(19): [PMID: 33003502]
  56. N Engl J Med. 1995 Oct 26;333(17):1146-8 [PMID: 7565955]
  57. Biochem Biophys Res Commun. 2014 Sep 26;452(3):715-21 [PMID: 25195818]
  58. Apoptosis. 2008 Jun;13(6):822-32 [PMID: 18461459]
  59. Exp Oncol. 2012 Oct;34(3):231-42 [PMID: 23070008]
  60. PLoS One. 2019 Jul 26;14(7):e0219531 [PMID: 31348786]
  61. PLoS One. 2014 Mar 27;9(3):e92887 [PMID: 24675771]
  62. J Neurochem. 2015 Jun;133(5):708-21 [PMID: 25753028]
  63. Annu Rev Genet. 2005;39:359-407 [PMID: 16285865]
  64. J Occup Environ Med. 2000 May;42(5):491-501 [PMID: 10824302]
  65. Med Sci Monit. 2021 May 10;27:e933015 [PMID: 34016942]
  66. Am J Physiol Heart Circ Physiol. 2015 Nov;309(9):H1453-67 [PMID: 26386112]
  67. Lancet. 1999 Jan 16;353(9148):169-78 [PMID: 9923871]
  68. Headache. 2008 May;48(5):733-4 [PMID: 18471127]
  69. Iran J Child Neurol. 2021 Fall;15(4):115-117 [PMID: 34782849]
  70. Ann Clin Lab Sci. 1998 Mar-Apr;28(2):67-81 [PMID: 9558445]
  71. AIDS Rev. 2004 Jul-Sep;6(3):169-80 [PMID: 15595434]
  72. J Leukoc Biol. 2022 Jul;112(1):23-29 [PMID: 35355308]
  73. Duodecim. 2009;125(3):297-300 [PMID: 19341043]
  74. Front Physiol. 2022 Feb 04;12:805005 [PMID: 35185603]
  75. Occup Environ Med. 2001 May;58(5):291-8 [PMID: 11303077]
  76. Neurotoxicology. 2015 Dec;51:67-79 [PMID: 26409647]
  77. J Gerontol. 1994 Mar;49(2):M85-94 [PMID: 8126356]
  78. Neural Comput. 2014 Nov;26(11):2594-651 [PMID: 25149705]
  79. J Neurochem. 2017 Aug;142(3):444-455 [PMID: 28500787]
  80. Expert Opin Drug Metab Toxicol. 2015 Jan;11(1):15-24 [PMID: 25331002]
  81. Cell Death Differ. 2008 Oct;15(10):1619-28 [PMID: 18566603]
  82. Nutr Neurosci. 2020 Aug;23(8):640-645 [PMID: 30404563]
  83. Med Sci Sports Exerc. 2005 Dec;37(12):2086-93 [PMID: 16331134]
  84. Occup Environ Med. 2001 May;58(5):299-306 [PMID: 11303078]
  85. J Nutr. 2014 Aug;144(8):1211-8 [PMID: 24899159]
  86. Toxicology. 2005 Mar 15;208(2):273-88 [PMID: 15691591]
  87. PLoS One. 2013 Jun 14;8(6):e63903 [PMID: 23798990]
  88. BMC Public Health. 2004 Jul 13;4:27 [PMID: 15251045]
  89. Nat Biotechnol. 2014 Apr;32(4):373-80 [PMID: 24658645]
  90. Int J Cardiol. 2008 Aug 1;128(1):e43-5 [PMID: 17689757]
  91. Neurotoxicology. 2016 Jan;52:127-33 [PMID: 26619911]
  92. JACC Heart Fail. 2014 Dec;2(6):641-9 [PMID: 25282031]
  93. J Nutr Biochem. 2021 Dec;98:108804 [PMID: 34171502]
  94. J Biol Chem. 2010 Nov 19;285(47):36818-27 [PMID: 20837491]
  95. J Environ Sci Health B. 2019;54(8):623-639 [PMID: 31033394]
  96. Brain Behav Immun. 2020 Jul;87:498-507 [PMID: 32027960]
  97. Am J Med. 2000 Jun 15;108(9):695-704 [PMID: 10924645]
  98. Neural Comput. 2018 Nov;30(11):2882-2985 [PMID: 30183509]
  99. Emerg Med J. 2002 Sep;19(5):386-90 [PMID: 12204981]
  100. Mil Med Res. 2021 Aug 17;8(1):46 [PMID: 34399857]
  101. Front Cell Dev Biol. 2021 Sep 17;9:736603 [PMID: 34604237]
  102. Indian J Physiol Pharmacol. 2004 Apr;48(2):150-64 [PMID: 15521554]
  103. Prog Brain Res. 2006;153:129-40 [PMID: 16876572]
  104. Am J Respir Cell Mol Biol. 2019 Jun;60(6):667-677 [PMID: 30571144]
  105. Brain Sci. 2021 Aug 26;11(9): [PMID: 34573153]
  106. PLoS One. 2016 Jun 28;11(6):e0157855 [PMID: 27352030]
  107. Oxid Med Cell Longev. 2020 May 22;2020:4858975 [PMID: 32566083]
  108. Indian J Dermatol Venereol Leprol. 2012 Sep-Oct;78(5):664 [PMID: 22960836]
  109. Psychol Rep. 2002 Apr;90(2):639-53 [PMID: 12061608]
  110. Free Radic Res. 2005 Nov;39(11):1147-54 [PMID: 16298740]
  111. AIDS. 2001 Sep 7;15(13):1687-94 [PMID: 11546944]
  112. Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4295-300 [PMID: 18332428]
  113. WMJ. 1999 Sep-Oct;98(6):26-9 [PMID: 10605352]
  114. Front Mol Neurosci. 2017 Jun 14;10:182 [PMID: 28659758]
  115. Proc Natl Sci Counc Repub China B. 1998 Apr;22(2):55-67 [PMID: 9615468]
  116. Toxicology. 2005 Mar 30;208(3):367-75 [PMID: 15695022]
  117. Neurotoxicol Teratol. 2018 Jan - Feb;65:1-13 [PMID: 29126934]
  118. Chemosphere. 2021 Dec;284:131250 [PMID: 34225124]
  119. Neuropathology. 2014 Apr;34(2):109-27 [PMID: 24118348]
  120. Neurotoxicology. 2007 Jul;28(4):761-9 [PMID: 17485118]
  121. Int J Environ Res Public Health. 2019 Mar 16;16(6): [PMID: 30884809]
  122. Oral Dis. 2023 May;29(4):1812-1825 [PMID: 35146845]
  123. Toxicol Appl Pharmacol. 2022 Jan 1;434:115820 [PMID: 34896432]
  124. Metabolism. 2012 Jul;61(7):954-65 [PMID: 22209670]
  125. Neurobiol Aging. 1999 Sep-Oct;20(5):565-71 [PMID: 10638530]
  126. Am J Prev Med. 2002 Oct;23(3):200-6 [PMID: 12350453]
  127. Metabolism. 2011 Nov;60(11):1598-609 [PMID: 21632075]
  128. Biochim Biophys Acta. 1995 May 24;1271(1):141-51 [PMID: 7599200]
  129. Biochem Biophys Res Commun. 2010 Jan 15;391(3):1567-72 [PMID: 20040361]
  130. Life Sci. 2021 Oct 15;283:119867 [PMID: 34358550]
  131. Semin Pediatr Neurol. 1996 Jun;3(2):59-98 [PMID: 8795843]
  132. Epidemiology. 1990 Jan;1(1):43-6 [PMID: 2081237]
  133. J Appl Physiol (1985). 1995 Jun;78(6):2131-9 [PMID: 7665409]
  134. Science. 1992 May 1;256(5057):628-32 [PMID: 1533953]
  135. Cytokine. 2015 Mar;72(1):1-8 [PMID: 25514671]
  136. Med Sci Monit. 2018 Mar 12;24:1484-1492 [PMID: 29528039]
  137. J Clin Invest. 2010 Jan;120(1):142-56 [PMID: 20038799]
  138. J Occup Environ Med. 1998 Jun;40(6):520-8 [PMID: 9636932]
  139. Pharmacol Biochem Behav. 2005 Apr;80(4):529-40 [PMID: 15820522]
  140. Autism Res. 2018 Jan;11(1):175-184 [PMID: 28861935]
  141. Environ Toxicol. 2020 Oct;35(10):1033-1042 [PMID: 32478940]
  142. Environ Pollut. 2021 Apr 1;274:116541 [PMID: 33529899]
  143. PLoS One. 2018 Apr 11;13(4):e0193120 [PMID: 29641571]
  144. Ann Clin Biochem. 1998 Sep;35 ( Pt 5):671-3 [PMID: 9768335]
  145. J Hum Hypertens. 2007 Apr;21(4):297-306 [PMID: 17287847]
  146. Biosci Rep. 2007 Jun;27(1-3):53-67 [PMID: 17492503]
  147. Int J Biochem Cell Biol. 2005 Apr;37(4):901-8 [PMID: 15694848]
  148. J Environ Sci Health B. 2016;51(6):366-73 [PMID: 26950528]
  149. J Neurol Neurosurg Psychiatry. 1993 Aug;56(8):900-5 [PMID: 8350109]
  150. Toxicology. 2016 Nov 30;372:22-33 [PMID: 27931520]
  151. Am J Epidemiol. 2000 Nov 15;152(10):992-1002 [PMID: 11092441]
  152. Am J Hum Genet. 2003 Jun;72(6):1515-26 [PMID: 12730827]

Grants

  1. IK6 BX005229/BLRD VA
  2. #BX005229/VA

MeSH Term

Humans
C-Reactive Protein
Persian Gulf Syndrome
Mitochondria
Mitochondrial Membranes
Inflammation

Chemicals

C-Reactive Protein

Word Cloud

Created with Highcharts 10.0.0GWIVGWIseveritygreatermitochondrialsignificantlypredictedinflammationillnessMRCFsymptomsperipheralGulfWarimpairmentbiopsyCI&CIIOXPHOSrelatedcombinedsamplehsCRPimportantexemplarenvironmentally-triggeredchronicmultisymptompotentialmodelacceleratedagingInflammationmainhypothesizedmechanismalsoproposedstudydirectlyassessedrespiratorychainfunctionmuscleveteransrecruited42participantshalfmaterialsuccessfullysecured36ImpairedindexedcomplexIIoxidativephosphorylationglucosefuelsourceborderlinedirection1720LowerseparatelywithoutadjustmentHigher-hsCRPstronglylower-MRCFparticularlyfattyacidoxidationFAOindicescontrolsDespitewhereasMRCF-impairmentSurprisinglyadjustedhigherlessersymptomselectivelyFindingscomporthypothesisincreasedobserveddrivenFAO-defect-inducedapoptosisconclusionimpairedfunction-butinflammation-predictsMitochondrialpredicts

Similar Articles

Cited By